• Most Popular
  • Most Shared

UPDATE 1-Watson, Barr settle patent dispute over Oxytrol

Wed Oct 28, 2009 9:02am EDT

Stocks

   

CHICAGO, Oct 28 (Reuters) - Watson Pharmaceuticals (WPI.N)said it has reached an agreement to settle a patent dispute with Barr Pharmaceuticals over Watson's Oxytrol, or Oxybutynin Transdermal System product.

Stocks  |  Global Markets  |  Healthcare

Under terms of the settlement agreement, Watson has granted Barr a royalty-bearing license to the U.S. patents covering Oxytrol to start marketing a generic equivalent product on April 26, 2015, or earlier in certain circumstances.

Barr is owned by Teva Pharmaceutical Industries Ltd of Israel. (Reporting by Debra Sherman, Editing by Maureen Bavdek)

Stocks
Global Markets
Healthcare


More from Reuters

Photo

U.S. probing if al Qaeda linked to airplane incident

WASHINGTON (Reuters) - The United States is investigating whether al Qaeda was involved in a Christmas Day attempt to blow up a passenger jet, but there is no early evidence the Nigerian suspect in the case was part of a larger plot, the U.S. homeland security chief said on Sunday. | Video

» More Top News
A Delta Airbus 330 airliner sits on a runway at Detroit Metropolitan Airport in Romulus, Michigan in this video grab made December 25, 2009. Credit: REUTERS/WDIV TV/Handout

The battle in mid-air

The attraction of bombing airliners means the aviation industry has to be constantly vigilant in its fight against attackers.  Full Article 

U.S.
A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
Political Risk in 2010:

Don't say we didn't warn you

With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

Global Markets